Related Experiment Videos

Persistent chest pain following oral dipyridamole for thallium 201 myocardial imaging

A H Kwai1, A F Jacobson, K M McIntyre

  • 1Nuclear Medicine and Medical Services, Brockton/West Roxbury V.A. Medical Center, MA 02132.

Insights

A patient experienced prolonged chest pain and ST-segment elevation after a dipyridamole stress test. This rare complication highlights the need for immediate intervention during diagnostic imaging.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Nuclear Cardiology

Background:

  • Acute chest pain necessitates prompt cardiac evaluation.
  • Stress thallium 201 scintigraphy is a diagnostic tool for assessing myocardial perfusion.
  • Dipyridamole is a pharmacologic stress agent used in scintigraphy.

Observation:

  • A patient presented with acute chest pain, and acute myocardial infarction was excluded.
  • During a stress thallium 201 scintigraphy with oral dipyridamole, the patient developed persistent angina.
  • The patient also exhibited ST-segment elevation, a sign of severe myocardial ischemia.

Findings:

  • Persistent angina and ST-segment elevation occurred as a complication of dipyridamole administration.
  • This specific complication following dipyridamole stress testing has not been previously documented in medical literature.
  • The event suggests a potential for severe ischemic reactions to pharmacologic stress agents.

Implications:

  • Clinicians should be prepared for potential severe ischemic complications during dipyridamole stress tests.
  • Availability of immediate intervention protocols is crucial for managing adverse events.
  • This case underscores the importance of vigilant patient monitoring during diagnostic cardiac imaging procedures.

Related Concept Videos